Rationale and methodology of the multicenter pediatric cerebrospinal fluid shunt design trial. Pediatric Hydrocephalus Treatment Evaluation Group
- PMID: 8891361
- DOI: 10.1007/BF00261620
Rationale and methodology of the multicenter pediatric cerebrospinal fluid shunt design trial. Pediatric Hydrocephalus Treatment Evaluation Group
Abstract
Cerebrospinal fluid shunt failure remains a common and at times overwhelming problem in pediatric patients with hydrocephalus. Two new shunt valve designs, the Orbis-Sigma (Cordis Corporation, Miami, Florida) and the Delta valve (PS Medical, Goletta, California), have flow/pressure characteristics dramatically different from those of standard differential pressure valves which have been used for over three decades. Both new designs reduce the siphoning effect in the upright position, and have been reported to reduce shunt failure rates in uncontrolled series, allegedly due to reduction in shunt overdrainage. Most mechanical shunt failure in the first 2 years after implantation is due to proximal shunt obstruction, overdrainage, and loculated ventricles. By reducing the incidence of slit ventricles associated with standard valves, both new designs could be envisioned as reducing the early mechanical complications. The improved results with both new valves could, however, also be to a large extent due to other confounding effects of shunt surgery, including patient selection, surgical technique, and specific configuration of the components of the shunt other than the valve. There are also theoretical reasons why these valve designs might be worse than their predecessors, including the narrow orifice and high resistance of the Orbis-Sigma, and the flexible membrane of the siphon control portion of the Delta valve, which may increase the ventricular pressure in the upright position or become blocked by encasing scar tissue. For this reason a randomized trial is required to determine efficacy, and a standard differential pressure valve is required as the control design. A significant reduction in early shunt failure would dramatically improve the morbidity and mortality of pediatric hydrocephalic patients, as well as providing substantial savings to the health care system. Failure to determine any difference would focus attention on other issues surrounding shunt surgery, such as patient characteristics or surgical technique.
Similar articles
-
Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.Neurosurgery. 1998 Aug;43(2):294-303; discussion 303-5. doi: 10.1097/00006123-199808000-00068. Neurosurgery. 1998. PMID: 9696082 Clinical Trial.
-
Change in ventricular size and effect of ventricular catheter placement in pediatric patients with shunted hydrocephalus.Neurosurgery. 1999 Dec;45(6):1329-33; discussion 1333-5. doi: 10.1097/00006123-199912000-00012. Neurosurgery. 1999. PMID: 10598700 Clinical Trial.
-
CSF shunts 50 years on--past, present and future.Childs Nerv Syst. 2000 Nov;16(10-11):800-4. doi: 10.1007/s003810000351. Childs Nerv Syst. 2000. PMID: 11151733 Review.
-
Laboratory testing of hydrocephalus shunts -- conclusion of the U.K. Shunt evaluation programme.Acta Neurochir (Wien). 2002 Jun;144(6):525-38; discussion 538. doi: 10.1007/s00701-002-0922-9. Acta Neurochir (Wien). 2002. PMID: 12111485
-
[Overdrainage in the treatment of hydrocephalus].Pediatrie. 1991;46(8-9):617-23. Pediatrie. 1991. PMID: 1660122 Review. French.
Cited by
-
Shunt survival rates by using the adjustable differential pressure valve combined with a gravitational unit (proGAV) in pediatric neurosurgery.Childs Nerv Syst. 2013 Mar;29(3):425-31. doi: 10.1007/s00381-012-1956-9. Epub 2012 Nov 8. Childs Nerv Syst. 2013. PMID: 23135777
-
Use of Fetal Magnetic Resonance Image Analysis and Machine Learning to Predict the Need for Postnatal Cerebrospinal Fluid Diversion in Fetal Ventriculomegaly.JAMA Pediatr. 2018 Feb 1;172(2):128-135. doi: 10.1001/jamapediatrics.2017.3993. JAMA Pediatr. 2018. PMID: 29255892 Free PMC article.
-
The modernization of pediatric neurosurgery. The Donald D. Matson Lecture 2003.Childs Nerv Syst. 2004 Jan;20(1):18-22. doi: 10.1007/s00381-003-0838-6. Epub 2003 Dec 2. Childs Nerv Syst. 2004. PMID: 14652685
-
Ventriculo-peritoneal shunting devices for hydrocephalus.Cochrane Database Syst Rev. 2020 Jun 16;6(6):CD012726. doi: 10.1002/14651858.CD012726.pub2. Cochrane Database Syst Rev. 2020. PMID: 32542676 Free PMC article.
-
Long-term outcome of hydrocephalus management in myelomeningoceles.Childs Nerv Syst. 2003 Jun;19(5-6):286-91. doi: 10.1007/s00381-003-0759-4. Epub 2003 May 23. Childs Nerv Syst. 2003. PMID: 12764629
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical